Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 8,499

Sort by:

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, 2019 provides an overview of the pipeline landscape of Attention Deficit Hyperactivity Disorder (ADHD) It provide...

November 2019 150 pages

Behcets Disease - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Behcets Disease - Pipeline Review, 2019 provides an overview of the pipeline landscape of Behcets Disease It provides comprehensive insights of all the clinical and non-clinical th...

November 2019 150 pages

Beta Thalassemia - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Beta Thalassemia - Pipeline Review, 2019 provides an overview of the pipeline landscape of Beta Thalassemia It provides comprehensive insights of all the clinical and non-clinical...

November 2019 150 pages

Bipolar Disorder - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Bipolar Disorder - Pipeline Review, 2019 provides an overview of the pipeline landscape of Bipolar DisorderIt provides comprehensive insights of all the clinical and non-clinical t...

November 2019 150 pages

Bronchopulmonary Dysplasia - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Bronchopulmonary Dysplasia - Pipeline Review, 2019 provides an overview of the pipeline landscape of Bronchopulmonary Dysplasia It provides comprehensive insights of all the clinic...

November 2019 150 pages

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, 2019 provides an overview of the pipeline landscape of Chronic Inflammatory Demyelinating Polyneuropathy...

November 2019 150 pages

Chronic Myeloid Leukemia - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Chronic Myeloid Leukemia - Pipeline Review, 2019 provides an overview of the pipeline landscape of Chronic Myeloid Leukemia It provides comprehensive insights of all the clinical a...

November 2019 150 pages

Chronic Obstructive Pulmonary Disease - Pipeline Review, 2019

US$ 1,400.00

Firstview Insight's Chronic Obstructive Pulmonary Disease - Pipeline Review, 2019 provides an overview of the pipeline landscape of Chronic Obstructive Pulmonary Disease It provides comprehensive insi...

November 2019 150 pages

Colorectal cancer - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Colorectal cancer - Pipeline Review, 2019 provides an overview of the pipeline landscape of Colorectal cancerIt provides comprehensive insights of all the clinical and non-clinical...

November 2019 150 pages

Cystic fibrosis - Pipeline Review, 2019

US$ 1,400.00

Firstview Insight's Cystic fibrosis - Pipeline Review, 2019 provides an overview of the pipeline landscape of Cystic fibrosis It provides comprehensive insights of all the clinical and non-clinical th...

November 2019 150 pages

Duchenne muscular dystrophy - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Duchenne muscular dystrophy - Pipeline Review, 2019 provides an overview of the pipeline landscape of Duchenne muscular dystrophyIt provides comprehensive insights of all the clini...

November 2019 150 pages

Ewing Sarcoma - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Ewing Sarcoma - Pipeline Review, 2019 provides an overview of the pipeline landscape of Ewing Sarcoma It provides comprehensive insights of all the clinical and non-clinical therap...

November 2019 150 pages

Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, 2019 provides an overview of the pipeline landscape of Keratoconjunctivitis sicca (Dry Eye) It provides comprehensive insigh...

November 2019 120 pages

Latestage chronic kidney disease (CKD) - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Latestage chronic kidney disease (CKD) - Pipeline Review, 2019 provides an overview of the pipeline landscape of Latestage chronic kidney disease (CKD) It provides comprehensive in...

November 2019 120 pages

Leber Hereditary Optic Neuropathy - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Leber Hereditary Optic Neuropathy - Pipeline Review, 2019 provides an overview of the pipeline landscape of Leber Hereditary Optic Neuropathy It provides comprehensive insights of...

November 2019 120 pages

Liver cancer - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Liver cancer - Pipeline Review, 2019 provides an overview of the pipeline landscape of Liver cancer It provides comprehensive insights of all the clinical and non-clinical therapeu...

November 2019 120 pages

Macular Edema - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Macular Edema - Pipeline Review, 2019 provides an overview of the pipeline landscape of Macular Edema It provides comprehensive insights of all the clinical and non-clinical therap...

November 2019 120 pages

Major depressive disorder - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Major depressive disorder - Pipeline Review, 2019 provides an overview of the pipeline landscape of Major depressive disorderIt provides comprehensive insights of all the clinical...

November 2019 120 pages

Mantle Cell Lymphoma - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Mantle Cell Lymphoma - Pipeline Review, 2019 provides an overview of the pipeline landscape of Mantle Cell Lymphoma It provides comprehensive insights of all the clinical and non-c...

November 2019 120 pages

Medullary Thyroid Cancer - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Medullary Thyroid Cancer - Pipeline Review, 2019 provides an overview of the pipeline landscape of Medullary Thyroid Cancer It provides comprehensive insights of all the clinical a...

November 2019 120 pages

Medulloblastoma - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Medulloblastoma - Pipeline Review, 2019 provides an overview of the pipeline landscape of Medulloblastoma It provides comprehensive insights of all the clinical and non-clinical th...

November 2019 120 pages

Merkel Cell Carcinoma - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Keratoconjunctivitis sicca (Dry Eye) - Pricing and Market Access provides country specific insights in order to estimate market potential for Keratoconjunctivitis sicca (Dry Eye) b...

November 2019 120 pages

Myelodysplastic Syndrome - Pipeline Review, 2019

US$ 1,250.00

Firstview Insight's Myelodysplastic Syndrome - Pipeline Review, 2019 provides an overview of the pipeline landscape of Myelodysplastic Syndrome It provides comprehensive insights of all the clinical a...

November 2019 150 pages

Non Small cell Lung cancer(NSCLC) - Pipeline Review, 2019

US$ 1,250.00

FirstView Market Insight ' Non Small cell Lung cancer(NSCLC)- Pipeline Review, 2019' provides an overview of the pipeline landscape. It provides comprehensive insights of all the clinical and non-clin...

November 2019 182 pages

Ulcerative colitis - Pipeline Review, 2019

US$ 1,250.00

FirstView Market Insight 'Ulcerative Colitis- Pipeline Review, 2019' provides an overview of the pipeline landscape for Ulcerative Colitis- Pipeline Review, 2019. It provides comprehensive insights of...

November 2019 146 pages

Indonesia and Philippines Vitamins and Nutraceuticals Market Outlook and Projections, 2019-2027

US$ 4,150.00

Functional beverages is slated to account for a share of 39.13% in 2018 in the Indonesia vitamins and nutraceuticals market. The growth of this segment can be attributed to the rising health concerns,...

November 2019 137 pages

Global Oral Anti-Diabetic Drugs Market: World Market Review and Analysis By Type, By Region, By Country (2019 Edition): Opportunities and Forecast (2019-2024)

US$ 2,400.00

EXECUTIVE SUMMARY The Oral anti diabetes drug was valued at USD 25.6 Billion in the year 2018. Over the recent years, oral anti-diabetes drug has been witnessing considerable growth on the back of r...

October 2019 275 pages

Global Schizophrenia Drugs (Orals & Injectables) Market: Insights, Trends and Forecast (2019-2023)

US$ 1,600.00

The global schizophrenia market is estimated to reach US$10.43 billion in 2023, growing at a CAGR of 3.69%, for the period spanning from 2018 to 2023. The factors such as rising occurrence of schizoph...

October 2019 95 pages

Acinetobacter Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Acinetobacter Infections Drug pipeline report- 2020 is an annual R&D review of Acinetobacter Infections pipeline candidates. The report presents the current status of all major Acinetobacter Infection...

October 2019 150 pages

African Trypanosomiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

African Trypanosomiasis Drug pipeline report- 2020 is an annual R&D review of African Trypanosomiasis pipeline candidates. The report presents the current status of all major African Trypanosomiasis t...

October 2019 40 pages

Anthrax Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Anthrax Drug pipeline report- 2020 is an annual R&D review of Anthrax pipeline candidates. The report presents the current status of all major Anthrax therapeutic compounds. Detailed insights into Ant...

October 2019 70 pages

Aspergillosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Aspergillosis Drug pipeline report- 2020 is an annual R&D review of Aspergillosis pipeline candidates. The report presents the current status of all major Aspergillosis therapeutic compounds. Detailed...

October 2019 80 pages

Bacillary Dysentery (Shigellosis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Bacillary Dysentery (Shigellosis) Drug pipeline report- 2020 is an annual R&D review of Bacillary Dysentery (Shigellosis) pipeline candidates. The report presents the current status of all major Bacil...

October 2019 40 pages

Bacterial Vaginosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Bacterial Vaginosis Drug pipeline report- 2020 is an annual R&D review of Bacterial Vaginosis pipeline candidates. The report presents the current status of all major Bacterial Vaginosis therapeutic c...

October 2019 50 pages

Botulism Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Botulism Drug pipeline report- 2020 is an annual R&D review of Botulism pipeline candidates. The report presents the current status of all major Botulism therapeutic compounds. Detailed insights into...

October 2019 40 pages

Burkholderia pseudomallei Infections (Melioidosis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Burkholderia pseudomallei Infections (Melioidosis) Drug pipeline report- 2020 is an annual R&D review of Burkholderia pseudomallei Infections (Melioidosis) pipeline candidates. The report presents the...

October 2019 50 pages

Candidiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Candidiasis Drug pipeline report- 2020 is an annual R&D review of Candidiasis pipeline candidates. The report presents the current status of all major Candidiasis therapeutic compounds. Detailed insig...

October 2019 130 pages

Chagas Disease (American Trypanosomiasis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Chagas Disease (American Trypanosomiasis) Drug pipeline report- 2020 is an annual R&D review of Chagas Disease (American Trypanosomiasis) pipeline candidates. The report presents the current status of...

October 2019 70 pages

Chikungunya Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Chikungunya Fever Drug pipeline report- 2020 is an annual R&D review of Chikungunya Fever pipeline candidates. The report presents the current status of all major Chikungunya Fever therapeutic compoun...

October 2019 80 pages

Chlamydia Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Chlamydia Infections Drug pipeline report- 2020 is an annual R&D review of Chlamydia Infections pipeline candidates. The report presents the current status of all major Chlamydia Infections therapeuti...

October 2019 50 pages

Cholera Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Cholera Drug pipeline report- 2020 is an annual R&D review of Cholera pipeline candidates. The report presents the current status of all major Cholera therapeutic compounds. Detailed insights into Cho...

October 2019 50 pages

Coccidioidomycosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Coccidioidomycosis Drug pipeline report- 2020 is an annual R&D review of Coccidioidomycosis pipeline candidates. The report presents the current status of all major Coccidioidomycosis therapeutic comp...

October 2019 40 pages

Community Acquired Pneumonia Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Community Acquired Pneumonia Drug pipeline report- 2020 is an annual R&D review of Community Acquired Pneumonia pipeline candidates. The report presents the current status of all major Community Acqui...

October 2019 70 pages

Cryptococcosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Cryptococcosis Drug pipeline report- 2020 is an annual R&D review of Cryptococcosis pipeline candidates. The report presents the current status of all major Cryptococcosis therapeutic compounds. Detai...

October 2019 40 pages

Cryptosporidiosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Cryptosporidiosis Drug pipeline report- 2020 is an annual R&D review of Cryptosporidiosis pipeline candidates. The report presents the current status of all major Cryptosporidiosis therapeutic compoun...

October 2019 40 pages

Dengue Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Dengue Fever Drug pipeline report- 2020 is an annual R&D review of Dengue Fever pipeline candidates. The report presents the current status of all major Dengue Fever therapeutic compounds. Detailed in...

October 2019 150 pages

Diphtheria Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Diphtheria Drug pipeline report- 2020 is an annual R&D review of Diphtheria pipeline candidates. The report presents the current status of all major Diphtheria therapeutic compounds. Detailed insights...

October 2019 70 pages

Epstein–Barr Virus (HHV-4) Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Epstein–Barr Virus (HHV-4) Infections Drug pipeline report- 2020 is an annual R&D review of Epstein–Barr Virus (HHV-4) Infections pipeline candidates. The report presents the current status of all maj...

October 2019 90 pages

Genital Herpes Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Genital Herpes Drug pipeline report- 2020 is an annual R&D review of Genital Herpes pipeline candidates. The report presents the current status of all major Genital Herpes therapeutic compounds. Detai...

October 2019 70 pages

Gonorrhea Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,699.00

Gonorrhea Drug pipeline report- 2020 is an annual R&D review of Gonorrhea pipeline candidates. The report presents the current status of all major Gonorrhea therapeutic compounds. Detailed insights in...

October 2019 50 pages

Filters

Clear all